{"issuance_frequency":"","notes_translated":{"fr":"\"COVID-19 est une nouvelle maladie non identifiée auparavant chez l'homme. À l'heure actuelle il n'y a pas de vaccin ou de produit thérapeutique pour le COVID-19 qui est autorisé à traiter ou prévenir la maladie. L'épidémie de COVID-19 a donné lieu à un examen global des thérapies qui pourraient être utilisées pour traiter ou prévenir l'infection.\r\nAfin de faciliter un accès plus rapide à un vaccin ou à un produit thérapeutique pour COVID-19, le Ministère accélérera l'examen de toutes les présentations et demandes de produits de santé liées au COVID-19. Cela permettra d'assurer un accès rapide à de nouvelles thérapies sans compromettre l'innocuité, l'efficacité et la qualité des produits.\"\r\n","en":"COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications. Doing this will ensure timely access to novel therapies without compromising the safety, efficacy and quality of products.\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"b43b1bf3-2f7d-4dba-81e3-bbfa419f3882","metadata_created":"2020-04-03T17:00:54.286844","subject":["government_and_politics","health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-04-07T16:50:42.942248","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-04-03","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["éclosion de la COVID-19","pandémie","vaccin ou produit thérapeutique pour COVID-19","présentations et demandes de produits de santé."],"en":["COVID-19 outbreak","pandemic","vaccine for COVID-19","health product submissions and applications"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Avis : Examen accéléré des présentations et demandes de produits de santé liées au COVID-19","en":"Notice: Expedited Review of Health Product Submissions and Applications to address COVID-19 "},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"b43b1bf3-2f7d-4dba-81e3-bbfa419f3882","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"9cb4b802-5ba2-48dd-927d-c34bec7f5af9","related_relationship":"","name_translated":{"fr":"Avis : Examen accéléré des présentations et demandes de produits de santé liées au COVID-19","en":"Notice: Expedited Review of Health Product Submissions and Applications to address COVID-19 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Expedited Review of Health Product Submissions and Applications to address COVID-19 ","language":["en"],"created":"2020-04-03T17:00:54.445855","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/notice-expediated-review-health-products-covid-19.html","last_modified":null,"position":0,"revision_id":"34858d95-b2ed-43f9-a7a7-82f248e3f60e","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"b43b1bf3-2f7d-4dba-81e3-bbfa419f3882","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b869c250-9ee7-4132-8b2d-d018e4d2f228","related_relationship":"","name_translated":{"fr":"Avis : Examen accéléré des présentations et demandes de produits de santé liées au COVID-19","en":"Notice: Expedited Review of Health Product Submissions and Applications to address COVID-19 "},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Notice: Expedited Review of Health Product Submissions and Applications to address COVID-19 ","language":["fr"],"created":"2020-04-03T17:00:54.445865","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/avis-examen-accelere-presentations-produits-sante-covid-19.html","last_modified":null,"position":1,"revision_id":"34858d95-b2ed-43f9-a7a7-82f248e3f60e","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-04-03 00:00:00","date_created":"2020-03-18","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"b43b1bf3-2f7d-4dba-81e3-bbfa419f3882","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications. Doing this will ensure timely access to novel therapies without compromising the safety, efficacy and quality of products.\r\n","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Notice: Expedited Review of Health Product Submissions and Applications to address COVID-19 ","revision_id":"34858d95-b2ed-43f9-a7a7-82f248e3f60e"}